5300-202A Acute Contrast Reactions:
Rapid Identification, Appropriate Response, & Potential Pitfalls ARCHIVE

An Online Lecture recorded on Thursday, May 31, 2018
 

Target Audience
This educational activity is intended for radiologists, nurses, and radiologic technologists

IMPORTANT NOTE: This course expires July 1, 2021

If you want credit, this course must be completed (i.e. view course content PDF file), pass the posttest, AND print the certificate)
by no later than 5PM Eastern Standard Time on June 30, 2021

Please note, after this course has expired, no aspect of the course will be accessible, including the course material.

Format: Fee:	Archived Webinar Free
MD Credit: RT Credit: RN Credit:	1.0 AMA PRA Category 1 1.0 ARRT Category A 1.0 ANCC Contact hour

Course Overview
Millions of patients safely undergo contrast-enhanced imaging exams annually. Both iodinated and gadolinium-based contrast agents are associated with a low rate of adverse reactions, and those that do occur are typically mild or moderate and can be observed or treated successfully in the radiology suite. However, severe reactions do occur, may be life threatening, and require rapid aggressive treatment to minimize chance of patient harm. [1]

Medical imaging professionals need to identify and respond immediately to the signs and symptoms of a contrast reaction. However, studies have shown that radiologists are not always adequately prepared to treat patients in distress. [2] Continuous training of the radiology team ensures maintenance of knowledge and increased confidence in responding to a potential reaction or mimic.

This lecture will provide an overview on the type and incidence of contrast reactions, provide treatment algorithms, review common pitfalls and errors in treatment, and discuss the value of simulation models in team-based training in contrast reaction management.

1. Hunt CH, Hartman RP, Hesley GK. Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: retrospective review of 456,930 doses. AJR Am J Roentgenol. 2009;193(4):1124-1127.

2. Nandwana SB, Walls DG, Torres WE. Radiology Department Preparedness for the Management of Severe Acute Iodinated Contrast Reactions: Do We Need to Change Our Approach? AJR Am J Roentgenol. 2015 Jul;205(1):90-4.

Educational Objectives
At the conclusion of this activity, participants should be better able to:

• Review the types and incidences of adverse contrast reactions
• Review how to identify, treat, and manage adverse contrast reactions
• Emphasize common errors and potential pitfalls seen in contrast reaction management
• Review some of the benefits of simulation based training and other learning aids to help maintain knowledge and improve confidence in responding to contrast reactions

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing medical education for physicians.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

SA-CME: This activity meets the criteria for self-assessment toward the purpose of fulfilling requirements in the American Board of Radiology (ABR) Maintenance of Certification Program.

The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live event and e-learning materials.

For more information go to https://www.uems.eu/areas-of-expertise/cme-cpd/eaccme/mutual-recognition-with-the-united-states

Nurse Continuing Medical Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

Radiologic Technologists
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A continuing education credit.

How to Enroll and Participate
This program is offered by ICPME through WebEx webinar service at no charge to the learner.

• Click ENROLL NOW and follow the registration instructions to register with ICPME.
• You will receive an email from ICPME confirming your registration.
• At the end of the registration process, click on ACCESS WEBINAR.

How to Receive a Credit Certificate

• Log-in to your account at www.icpme.us
• View the entire educational activity session. At the conclusion of the lecture, close the Vimeo window.
• Return to the course in your account at www.icpme.us.
• From the COURSE HOME page, click the button for POSTTEST and for EVALUATION.
• A passing grade of at least 75% is required to receive credit. You may take the test up to three times.
• Upon receipt of a passing grade, you will be able to print a certificate of credit from your account at www.icpme.us

Your certificate of credit will remain in your account at www.icpme.us as a permanent record of your participation.

Faculty
Jay Pahade, MD

Dr. Pahade’s research interests focus on advancing patient-centered radiology; radiological contrast media for CT and MRI; and hepatic and pancreatic tumors. Of special interest is Dr. Pahade’s desire to improve patient safety related to the administration of CT and MRI contrast agents. He created and runs an annual high fidelity simulation program designed to train radiology faculty, technologists, and nurses on the proper management of contrast reactions. His research has demonstrated the efficacy of high fidelity stimulation training in improving management of contrast reactions and how to use visual aids to improve comfort and decrease error rates in reaction management. Dr. Pahade and colleagues have published their findings in The Journal of the American College of Radiology and the American Journal of Roentgenology.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Jay Pahade, MD, has nothing to disclose.

The ICPME and PIM planners and managers have nothing to disclose.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Questions?
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com

Jointly Provided by

This activity is supported by an independent educational grant from Bayer Healthcare Pharmaceuticals.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.